Screener
Medline, Inc. MDLN Payments to Noncontrolling Interests
Payments to Noncontrolling Interests at other companies
Other financials
Where this comes from
Reported directly by Medline, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToMinorityShareholders.
The source filing: Medline, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:48 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0002046386-26-000051
| (in millions) | Six months ended / June 27, 2026 | Six months ended / June 28, 2025 |
|---|---|---|
| Exercise of employee stock options | 1 | — |
| Settlement of taxes withheld on stock-based awards | (5) | — |
| Distributions to partners | — | (303) |
| Distributions to noncontrolling interests | (123) | — |
| Net cash used in financing activities | (172) | (337) |
| Effect of exchange rate changes on cash and cash equivalents and restricted cash | (11) | 27 |
| Net change in cash and cash equivalents and restricted cash | 387 | 334 |
| Cash, cash equivalents and restricted cash, beginning of year | 1,942 | 250 |
Item 1 - Financial Statements
FAQ
- What is Medline, Inc.'s payments to noncontrolling interests?
- Medline, Inc. (MDLN) reported payments to noncontrolling interests of $113M in Q2 2026.
- What does payments to noncontrolling interests mean?
- Payments to Noncontrolling Interests
Ask your AI about Medline, Inc.'s payments to noncontrolling interests.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude